A detailed history of Ameriprise Financial Inc transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Ameriprise Financial Inc holds 1,512,050 shares of JAZZ stock, worth $187 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,512,050
Previous 1,461,323 3.47%
Holding current value
$187 Million
Previous $156 Million 8.06%
% of portfolio
0.04%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.57 - $116.37 $5.1 Million - $5.9 Million
50,727 Added 3.47%
1,512,050 $169 Million
Q2 2024

Aug 14, 2024

BUY
$103.94 - $118.98 $9.6 Million - $11 Million
92,374 Added 6.75%
1,461,323 $156 Million
Q1 2024

May 15, 2024

BUY
$115.19 - $132.77 $6.47 Million - $7.46 Million
56,178 Added 4.28%
1,368,949 $165 Million
Q4 2023

Feb 14, 2024

BUY
$114.26 - $136.0 $1.5 Million - $1.79 Million
13,159 Added 1.01%
1,312,771 $161 Million
Q3 2023

Nov 14, 2023

BUY
$122.0 - $145.31 $7.04 Million - $8.39 Million
57,717 Added 4.65%
1,299,612 $168 Million
Q2 2023

Aug 14, 2023

BUY
$122.5 - $147.16 $8.45 Million - $10.2 Million
69,018 Added 5.88%
1,241,895 $154 Million
Q1 2023

May 15, 2023

BUY
$133.98 - $160.47 $4.94 Million - $5.91 Million
36,839 Added 3.24%
1,172,877 $172 Million
Q4 2022

Feb 14, 2023

BUY
$129.72 - $159.85 $16.8 Million - $20.7 Million
129,662 Added 12.88%
1,136,038 $181 Million
Q3 2022

Nov 14, 2022

BUY
$126.59 - $161.18 $20.2 Million - $25.7 Million
159,511 Added 18.84%
1,006,376 $134 Million
Q2 2022

Aug 15, 2022

BUY
$141.59 - $168.66 $53.5 Million - $63.7 Million
377,948 Added 80.6%
846,865 $132 Million
Q1 2022

May 16, 2022

BUY
$129.64 - $160.7 $8.78 Million - $10.9 Million
67,696 Added 16.87%
468,917 $72.5 Million
Q4 2021

Feb 14, 2022

BUY
$119.87 - $145.67 $33.7 Million - $41 Million
281,523 Added 235.19%
401,221 $50.6 Million
Q3 2021

Nov 15, 2021

SELL
$128.64 - $184.79 $4.9 Million - $7.04 Million
-38,109 Reduced 24.15%
119,698 $15.6 Million
Q2 2021

Aug 16, 2021

BUY
$160.2 - $186.42 $794,431 - $924,456
4,959 Added 3.24%
157,807 $28 Million
Q1 2021

May 17, 2021

SELL
$150.19 - $173.5 $11.8 Million - $13.6 Million
-78,255 Reduced 33.86%
152,848 $25.2 Million
Q4 2020

Feb 12, 2021

BUY
$140.71 - $165.05 $605,897 - $710,705
4,306 Added 1.9%
231,103 $38.1 Million
Q3 2020

Nov 16, 2020

BUY
$105.46 - $144.13 $10.6 Million - $14.5 Million
100,493 Added 79.56%
226,797 $32.3 Million
Q2 2020

Aug 14, 2020

SELL
$95.68 - $121.88 $839,017 - $1.07 Million
-8,769 Reduced 6.49%
126,304 $13.9 Million
Q1 2020

May 15, 2020

BUY
$87.74 - $152.74 $130,118 - $226,513
1,483 Added 1.11%
135,073 $13.5 Million
Q4 2019

Feb 14, 2020

BUY
$117.65 - $153.73 $1.16 Million - $1.52 Million
9,894 Added 8.0%
133,590 $20 Million
Q3 2019

Nov 14, 2019

BUY
$125.18 - $143.24 $1.51 Million - $1.73 Million
12,101 Added 10.84%
123,696 $15.8 Million
Q2 2019

Aug 14, 2019

BUY
$125.55 - $144.48 $747,524 - $860,233
5,954 Added 5.64%
111,595 $15.9 Million
Q1 2019

May 15, 2019

SELL
$121.81 - $142.95 $29.3 Million - $34.4 Million
-240,612 Reduced 69.49%
105,641 $15.1 Million
Q4 2018

Feb 14, 2019

BUY
$115.94 - $166.74 $24.8 Million - $35.6 Million
213,678 Added 161.18%
346,253 $42.9 Million
Q3 2018

Nov 14, 2018

SELL
$161.01 - $180.57 $271,462 - $304,441
-1,686 Reduced 1.26%
132,575 $22.3 Million
Q2 2018

Aug 14, 2018

SELL
$146.33 - $183.18 $5.87 Million - $7.35 Million
-40,099 Reduced 23.0%
134,261 $23.1 Million
Q1 2018

May 15, 2018

SELL
$135.59 - $157.16 $751,168 - $870,666
-5,540 Reduced 3.08%
174,360 $26.3 Million
Q4 2017

Feb 12, 2018

SELL
$131.06 - $150.39 $8.08 Million - $9.27 Million
-61,646 Reduced 25.52%
179,900 $24.2 Million
Q3 2017

Nov 07, 2017

BUY
$142.62 - $155.6 $34.4 Million - $37.6 Million
241,546
241,546 $35.3 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.76B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.